BRCA1 and breast cancer: Among humans, a large randomized trial of folic acid supplementation among participants with a history of colorectal adenomas found supplementation was associated with increased risk of ≥ 3 adenomas [29], and a prospective analysis of women with BRCA1/2 mutation found a positive association between plasma folate and breast cancer risk [46].